TMS Health Solutions Taking Services Closer to the People

Posted by ACioe1 on

Depression is the second known cause of disability worldwide. A sizeable percentage of patients suffering from resistant clinical depression do not respond to conventional medication and treatment regimes. Some patients develop intolerance to drugs used in the treatment of clinical depression. Such patients require a more innovative approach to treating them.

 

Trans-cranial Magnetic Stimulation is a drug-free, safe and noninvasive alternative therapy. It is effective in treating patients with acute depression, especially those who are resistant to other forms of treatment.


It is a brainchild of Dr. Richard Bermudes, and it was established in 2007. He named it TMS Health Solutions. Dr. Brad Hummel is the CEO while Dr. Richard Bermudes is the chief medical officer.

 

Its headquarters are in San Francisco. TMS Health Solutions works to make its services accessible. They have other branches in Oakland, Sacramento, Eldorado Hills, Roseville, and Burlingame where they offer trans-cranial stimulation therapy. They comprise of a group of clinicians with a focus on research, treating patients with mental illness such as clinical depression.

 

They showed their dedication to taking services closer to the people by recently opening the TMS therapy Roseville. The clinic is located close to the Caltrain and Millbrae stations, which makes it convenient for patients to locate it.

 

Highly qualified psychiatrists operate all TMS Health Solution Clinics. The most notable are Dr. Noah DeGaetano, a trained and board certified psycho-pharmacologist; Dr. Abel Bumgarner, an adult psychiatrist who is also board certified; and Dr. Richard Bermudes, a qualified psychiatrist. The three are in charge of the TMS therapy in Burlingame.

 

The food and drugs authority approved TMS therapy in 2008 as a safe alternative for the treatment of resistant clinical depression. The therapy is administered in about thirty sessions of forty-five minutes. They spread for between six and eight weeks and are outpatient based.

 

The therapies have minimal side effects, usually manifesting in headaches and muscle soreness. A small number of patients may experience seizures as a side effect of the therapy.

 

TMS therapy is effective in treating 30% to 60% of patients with resistant depression. A study done in France also showed that the patients have a reduced chance of recurrent depression once they complete the TMS therapy.

 

To make TMS therapy more accessible, the management of TMS Health Solutions ensures their patients have insurance cover. They help those without cover to get financial assistance. Insurance providers like Anthem, United Healthcare, Optum, Cigna and Blue Shield provide cover to patients in need of TMS therapy.